NMAA
NMTCB NMAA Nuclear Medicine Advanced Associate
PharmaceuticalsEnglish
Exam overviewPractice session
A patient is referred for Lu-177 PSMA-617 (Pluvicto) therapy for metastatic castration-resistant prostate cancer. Which prerequisite study is required before initiating therapy?
Loading your practice session…